The Health Service Executive (HSE) is continuing to fund a Peter McVerry Trust drug service with over €300,000 annually, despite a confidential evaluation finding "near-total failure in client engagement".

The 2025 evaluation by the Substance Use Regional Forum (SURF), which channels HSE funding for the project, also found there was "a clear failure to deliver essential services and value for money"....

...The Peter McVerry Trust (PMVT] also said that it met with SURF and the HSE on Monday "where it was agreed that PMVT will continue to provide the low threshold ARAS service throughout 2026, funded by the HSE/SURF, while the future focus of the service is reviewed to ensure it reflects current and emerging community needs".